Objectives: To assess how well pregnant women adhere to aspirin therapy aimed at
preventing preeclampsia at Tu Du Hospital. Methods: This study was cross-sectional
and included 182 pregnant women classified as high risk for preeclampsia. These
participants were between 24 and 36 weeks pregnant, received a prescription for
preventative aspirin, and visited Tu Du Hospital for prenatal checkups from 11/2024 to
5/2025. Results: The adherence rate to aspirin prophylaxis for preeclampsia in high-risk
pregnant women, assessed using the MMAS-8 questionnaire, was 25.3%. Statistically
significant factors associated with adherence were: a history of hypertensive disorders
during pregnancy and a family history of hypertension. Conclusion: The rate of pregnant
women at high risk of preeclampsia who use aspirin correctly for prevention is still very
low. Appropriate measures are needed in terms of approach and counseling to increase
treatment adherence among pregnant women in this group.
Keywords: Aspirin, follow-up, preeclampsia, prophylactic treatment, treatment
adherence.
